Serum Albumin as a Prognostic Biomarker for Febrile Neutropenia Outcome and Complications: A Prospective Observational Trial.

导出 LinkOut

翻译打印收藏纠错

作者： Jelena,Dimitrijević ^[1] ; Marina,Čalamać ^[1] ; Ognjen,Đurmez ^[1] ; Danijela,Krstić ^[2] ; Marko,Stojanović ^[3]

作者单位： Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. ^[1] Institute of Medical Chemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. ^[2] Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. ^[3]

关键词 Febrile neutropenia MASCC risk index cancer prognostic marker serum albumin

DOI 10.1177/11795549241281330

PMID 39323980

发布时间 2024-09-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Medicine Insights. Oncology

2024年18卷

11795549241281330页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Serum Albumin as a Prognostic Biomarker for Febrile Neutropenia Outcome and Complications: A Prospective Observational Trial.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Serum Albumin as a Prognostic Biomarker for Febrile Neutropenia Outcome and Complications: A Prospective Observational Trial.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

检索历史清除